Your browser doesn't support javascript.
loading
Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa.
Maag, Anja; van Rein, Nienke; Schuijt, Tim J; Kopatz, Wil F; Kruijswijk, Danielle; Thomassen, Stella; Hackeng, Tilman M; Camire, Rodney M; van der Poll, Tom; Meijers, Joost C M; Bos, Mettine H A; van 't Veer, Cornelis.
Afiliação
  • Maag A; Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Rein N; Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
  • Schuijt TJ; Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
  • Kopatz WF; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Kruijswijk D; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
  • Thomassen S; Clinical Chemistry and Hematology Laboratory, Hospital Gelderse Vallei Ede, Ede, the Netherlands.
  • Hackeng TM; Department of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Camire RM; Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van der Poll T; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands.
  • Meijers JCM; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands.
  • Bos MHA; Division of Hematology and the Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • van 't Veer C; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Thromb Haemost ; 20(2): 328-338, 2022 02.
Article em En | MEDLINE | ID: mdl-34773381
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fator V / Fator Xa Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fator V / Fator Xa Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda